InvaTech Pharma Solutions, LLC recalls Levocetirizine Dihydrochloride Tablets, USP, 5 mg 30-count bottle, Rx Only, Distributed by: Marlex Pharmceuticals, Inc.
Recalled December 9, 2020 · FDA recall D-0115-2021 · InvaTech Pharma Solutions
Hazard
Failed Impurities/Degradation Specifications: One lot of Levocetirizine dihydrochloride tablets 5 mg 30 count failed stability testing. · FDA Class III
Units
N/A
Sold at
Distributed Nationwide in the USA
Description
Failed Impurities/Degradation Specifications: One lot of Levocetirizine dihydrochloride tablets 5 mg 30 count failed stability testing.
Product
Levocetirizine Dihydrochloride Tablets, USP, 5 mg 30-count bottle, Rx Only, Distributed by: Marlex Pharmceuticals, Inc. New Castle, DE 19720. NDC 10135-0639-30
Manufacturer(s)
InvaTech Pharma Solutions, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →